| Erin Michelle Schellert, SLP | |
|
157 Cooperwyck Rd, Wentzville, MO 63385-5740 | |
| (423) 534-6765 | |
| Not Available |
| Full Name | Erin Michelle Schellert |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 157 Cooperwyck Rd, Wentzville, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053623215 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2008028430 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Erin Michelle Schellert, SLP 157 Cooperwyck Rd, Wentzville, MO 63385-5740 Ph: () - | Erin Michelle Schellert, SLP 157 Cooperwyck Rd, Wentzville, MO 63385-5740 Ph: (423) 534-6765 |
News Archive
SPINAL MODULATION, Inc., a privately held medical device company focused on developing devices to treat chronic pain, today announced that the results of its prospective, multicenter Dorsal Root Ganglion (DRG) Stimulation Clinical Trial will be presented by David Caraway, MD, PhD, Timothy Deer, MD and Robert Levy, MD, PhD at the 14th Annual North American Neuromodulation Society (NANS) meeting.
AVI BioPharma, Inc., a developer of RNA-based drugs, today announced that Hong Moulton, Ph.D., Director of Discovery Research, will give oral presentations highlighting improved analogues of AVI's phosphorodiamidate morpholino oligomer (PMO) chemistry at two upcoming scientific meetings.
Isotechnika Pharma Inc. announced today that Lux Biosciences, Inc. has commenced its pivotal Phase 3 trial using voclosporin for the treatment of non-infectious uveitis, a leading cause of vision loss and long-term disability.
Today at the Biotechnica / Bio-IT World Europe conference in Hannover, Germany, BIOBASE and CLC bio announced a partnership to integrate BIOBASE's comprehensive TRANSFAC® database with CLC bio's popular workbenches and award-winning server solution.
The Conference Board of Canada, the Heart and Stroke Foundation and the Canadian Cardiovascular Society will hold a press conference on Monday, February 8 to announce the findings of the report, The Canadian Heart Health Strategy: Risk Factors and Future Cost Implications.
› Verified 2 days ago
Rachel Anne Broom, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 280 Interstate Dr, Wentzville, MO 63385 Phone: 636-327-3800 Fax: 636-327-8611 | |
Andrea Marie Simmons, MS-CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 523 Crystal Stream Dr, Wentzville, MO 63385 Phone: 314-302-8798 | |
Lauren Dowdy, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Campus Dr, Wentzville, MO 63385 Phone: 636-327-3800 | |
Kate Maureen Mcdevitt, M.H.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 612 Blumhoff Ave, Wentzville, MO 63385 Phone: 636-327-3846 | |
Ms. Nikki Lynn Arand, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 280 Interstate Dr, Wentzville, MO 63385 Phone: 636-327-3800 Fax: 636-327-8611 | |
Kayla Kinsey, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1 Campus Dr, Wentzville, MO 63385 Phone: 636-327-3800 Fax: 636-327-8611 |